有谁支持中风的转化细胞治疗：请举手示意？
Who's in favor of translational cell therapy for stroke: STEPS forward please?
机构信息
Department of Neurology, Henry Ford Hospital, Detroit, MI, USA.
出版信息
Cell Transplant. 2009;18(7):691-3. doi: 10.3727/096368909X470883. Epub 2009 Sep 28.
Abstract
A consortium of translational stem cell and stroke experts from multiple academic institutes and biotechnology companies, under the guidance of the government (FDA/NIH), is missing. Here, we build a case for the establishment of this consortium if cell therapy for stroke is to advance from the laboratory to the clinic.
摘要
一个由多个学术机构和生物技术公司的转化干细胞和中风专家组成的联盟，在政府（FDA/NIH）的指导下，正在缺失。在这里，如果细胞疗法要从实验室推进到临床，我们就必须建立这样一个联盟。
相似文献
1
Who's in favor of translational cell therapy for stroke: STEPS forward please?有谁支持中风的转化细胞治疗：请举手示意？
Cell Transplant. 2009;18(7):691-3. doi: 10.3727/096368909X470883. Epub 2009 Sep 28.
2
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.中风的细胞治疗：开展临床试验前有待解决的遗留问题。
Stroke. 2009 Mar;40(3 Suppl):S146-8. doi: 10.1161/STROKEAHA.108.533091. Epub 2008 Dec 8.
3
Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.在桑福德·伯纳姆医学研究所与学术界以及制药/生物技术合作伙伴开展临床前药物发现的合作前期工作：基础设施、能力与运营模式
Comb Chem High Throughput Screen. 2014 Mar;17(3):272-89. doi: 10.2174/1386207317666140109124735.
4
Pluripotent stem cells in translation: a Food and Drug Administration-National Institutes of Health collaboration.转化医学中的多能干细胞：美国食品药品监督管理局-美国国立卫生研究院的合作
Stem Cells Transl Med. 2013 Jul;2(7):483-7. doi: 10.5966/sctm.2013-0042. Epub 2013 Jun 11.
5
Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation.制定 NIH 联盟以进行 CARdioprotective 疗法的临床前评估（CAESAR）：梗塞面积限制研究中的范式转变。
J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):332-9. doi: 10.1177/1074248411414155.
6
Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke.急性缺血性卒中治疗药物NXY-059研发过程中“卒中治疗加速倡议”（STAIR）方案缺失的步骤：转化医学视角
J Cereb Blood Flow Metab. 2008 Jan;28(1):217-9. doi: 10.1038/sj.jcbfm.9600516. Epub 2007 Jun 20.
7
Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012.基因治疗罕见病：美国国立卫生研究院研讨会总结，2012 年 9 月 13 日。
Hum Gene Ther. 2013 Apr;24(4):355-62. doi: 10.1089/hum.2013.064.
8
Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells.细胞疗法治疗中风：重点在于优化内皮祖细胞的安全性和疗效特征。
Curr Pharm Des. 2012;18(25):3731-4. doi: 10.2174/138161212802002733.
9
Outcry over plans for 'Japanese NIH'.对“日本国立卫生研究院”计划的强烈抗议。
Nature. 2013 Jul 11;499(7457):136-7. doi: 10.1038/499136a.
10
NIH TRND program: successes in preclinical therapeutic development.美国国立卫生研究院转化研究网络计划：临床前治疗开发的成功案例
Trends Pharmacol Sci. 2013 Feb;34(2):87-9. doi: 10.1016/j.tips.2012.10.001. Epub 2012 Nov 19.
引用本文的文献
1
Neuroinflammation, Stem Cells, and Stroke.神经炎症、干细胞与中风
Stroke. 2022 May;53(5):1460-1472. doi: 10.1161/STROKEAHA.121.036948. Epub 2022 Apr 5.
2
The brain and eye: Treating cerebral and retinal ischemia through mitochondrial transfer.大脑和眼睛：通过线粒体转移治疗脑和视网膜缺血。
Exp Biol Med (Maywood). 2019 Nov;244(16):1485-1492. doi: 10.1177/1535370219881623. Epub 2019 Oct 11.
3
Nonhuman primate model in clinical modeling of diseases for stem cell therapy.用于干细胞治疗疾病临床建模的非人灵长类动物模型。
Brain Circ. 2016 Jul-Sep;2(3):141-145. doi: 10.4103/2394-8108.192524. Epub 2016 Oct 18.
4
Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.同种异体骨髓间充质干细胞鞘内注射治疗严重缺血性脑卒中患者的随机对照观察者盲法试验研究方案。
Transl Stroke Res. 2019 Apr;10(2):170-177. doi: 10.1007/s12975-018-0634-y. Epub 2018 May 23.
5
Preclinical Studies of Stem Cell Transplantation in Intracerebral Hemorrhage: a Systemic Review and Meta-Analysis.脑出血干细胞移植的临床前研究：一项系统评价与荟萃分析
Mol Neurobiol. 2016 Oct;53(8):5269-77. doi: 10.1007/s12035-015-9441-6. Epub 2015 Sep 26.
6
Bone Marrow Endothelial Progenitor Cell Transplantation After Ischemic Stroke: An Investigation Into Its Possible Mechanism.缺血性中风后骨髓内皮祖细胞移植：其可能机制的研究
CNS Neurosci Ther. 2015 Nov;21(11):877-86. doi: 10.1111/cns.12447. Epub 2015 Sep 19.
7
Stem cell therapy in intracerebral hemorrhage rat model.脑出血大鼠模型中的干细胞治疗
World J Stem Cells. 2015 Apr 26;7(3):618-29. doi: 10.4252/wjsc.v7.i3.618.
8
One, two, three steps toward cell therapy for stroke.迈向中风细胞疗法的一二三步骤。
Stroke. 2015 Feb;46(2):588-91. doi: 10.1161/STROKEAHA.114.007105. Epub 2014 Dec 11.
9
An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside.干细胞治疗中风从实验室到临床应用的最新进展
J Clin Med. 2013 Dec;2(4):220-241. doi: 10.3390/jcm2040220.
10
Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke.羊膜液源性干细胞移植治疗实验性缺血性脑卒中的疗效。
Front Cell Neurosci. 2014 Aug 13;8:227. doi: 10.3389/fncel.2014.00227. eCollection 2014.
本文引用的文献
1
Transplantation of hNT neurons into the ischemic cortex: cell survival and effect on sensorimotor behavior.将人神经干细胞来源的神经元移植到缺血皮层：细胞存活及对感觉运动行为的影响。
J Neurosci Res. 2006 May 1;83(6):1004-14. doi: 10.1002/jnr.20800.
2
Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke.在中风的神经保护中，外周注射的脐带血细胞进入中枢神经系统并非必要条件。
Stroke. 2004 Oct;35(10):2385-9. doi: 10.1161/01.STR.0000141680.49960.d7. Epub 2004 Sep 2.
3
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats.大鼠脑缺血后静脉注射骨髓基质细胞的治疗益处。
Stroke. 2001 Apr;32(4):1005-11. doi: 10.1161/01.str.32.4.1005.
4
Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats.冷冻保存的人胚胎癌衍生神经元（NT2N细胞）移植可促进缺血大鼠的功能恢复。
Exp Neurol. 1998 Feb;149(2):310-21. doi: 10.1006/exnr.1997.6730.
5
Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex.
Brain Res Mol Brain Res. 1994 Oct;26(1-2):61-8. doi: 10.1016/0169-328x(94)90074-4.
6
Homologous species restriction in lysis of erythrocytes by terminal complement proteins.终末补体蛋白对红细胞溶解的同源物种限制
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5118-21. doi: 10.1073/pnas.78.8.5118.
Zotero 插件